L-asparaginase treatment of acute myeloblastic leukemia.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001216:Asparagine / Q000096:biosynthesis; D004796:Clinical Enzyme Tests; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000970:Antineoplastic Agents; D001216:Asparagine; D001215:Asparaginase